CLINUVEL PHARMACEUTICALS LTD in Melbourne, Victoria, Australia | Biotechnology company

CLINUVEL PHARMACEUTICALS LTD

Locality: Melbourne, Victoria, Australia

Phone: +61 3 9660 4900

Address: 535 Bourke Street 3000 Melbourne, VIC, Australia

Website: http://www.clinuvel.com/

Likes: 3300

Add/Update information

Reviews

Tags

• Medical and health
• Biotechnology company

25.01.2022 If caught early, most skin cancers, including melanoma, can be treated successfully with minor surgery. Quick detection is the key. Learn more about skin cancer: https://bit.ly/3cDiljq #skincancer #skincancerawarness #worldcancerday #sunprotection #photoprotection #skincancerscreening

25.01.2022 Chair of the Board Willem Blijdorp lays out CLINUVEL’s vision for the future and the Group’s expansion in a letter to shareholders released today. Read the full announcement here: https://bit.ly/3pATHnH

22.01.2022 In a clinical update released today, CLINUVEL has given further details on the use of afamelanotide in the first xeroderma pigmentosum patient, who is receiving treatment as part of the Company’s DNA Repair Program. The XP-C patient commenced treatment in September under a Special Access Program and has been closely monitored by the expert clinical centre responsible for medical care. To date, the melanocortin drug has been well tolerated by the patient and no drug related a...dverse events have been reported. Clinical Operations Manager, Dr Pilar Bilbao said. This positive observation and clinical feedback from the treating physician form the basis for progressing the planned XP study, CUV150. For more details, head to our website: https://bit.ly/2HymYOn

22.01.2022 Central to CLINUVEL’s growth is a diverse mix of talent, including both young professionals and highly experienced specialists. In his most recent letter, CUV chairman Willem Blijdorp highlights the role of the team in growing the Group: https://bit.ly/3pATHnH

22.01.2022 CLINUVEL today announced that the Australian Therapeutic Goods Administration (TGA) has approved SCENESSE for adult erythropoietic protoporphyria (EPP) patients in Australia. The drug is the first approved therapy for EPP in Australia and is indicated for the prevention of phototoxicity in adult EPP patients, following a nine-month review by the TGA. SCENESSE will be available by prescription in Australia and administered by trained and accredited healthcare professionals.... Read the full announcement here: https://bit.ly/31IzTo8 #EPP #raredisease #drugapproval

21.01.2022 Following two decades of research and use of afamelanotide, CLINUVEL can now progress to evaluating how the molecule may be able to treat other indications, including life threatening diseases such as arterial ischemic stroke. Read more here: https://bit.ly/3mqSBIw #IschaemicStroke #stroketreatment #Stroke

20.01.2022 CLINUVEL has a diverse international team. What makes them tick? Read more about the CLINUVEL team in our latest News post and follow us to learn more in the coming weeks about what motivates and inspires them day to day. #insiderinsights #meettheteam #clinuvellians

20.01.2022 More than 45 million people worldwide have been diagnosed with vitiligo. Each has a different experience to tell, yet few are represented or heard. Over the upcoming weeks we will be sharing real life stories from people currently living with vitiligo. During this period, CLINUVEL’s Instagram and Facebook channels will be dedicated as a platform for all the voices of vitiligo. We hope by sharing individual experiences, we can help increase common awareness around this disea...se and, more importantly, open up new discussions. Join us in telling your unique story using the hashtag #45millionvitiligovoices. #vitiligo #awareness #knowledgesharing

20.01.2022 Click the link to read the media release issued following today’s announcement: https://bit.ly/37Jftz5 #EPP #raredisease #drugapproval #Australia #Biotech

19.01.2022 The risks of skin cancer are well known and understood. However, as prevalence continues to rise, photo-protection compliance amongst fair-skinned populations remains poor. Read our latest publication brief to understand how this worrying trend is being mapped and mitigated by the scientific community |CLINUVEL NEWS: https://bit.ly/37Af81m #skincancer #skincancerawareness #skincancerprevention

18.01.2022 CLINUVEL today announced the first clinical study of afamelanotide in arterial ischemic stroke (AIS) patients. The pilot study (CUV 801) will evaluate the safety of afamelanotide in six AIS patients. Click the link to read the full announcement: https://bit.ly/2HGYZwa ... #ClinicalTrials #IschaemicStroke #Biotech

16.01.2022 Today is World Cancer Day. We want to bring awareness to a disease relevant to CLINUVEL’s work, skin cancer. Research by the American Academy of Dermatology shows the number of annual diagnoses is rising at alarming rates, with it being one of the most common cancers in people younger than 30. Take action by learning how to prevent #skincancer. Read here: https://bit.ly/3cz7abv #skincancerawarness #worldcancerday #sunprotection #photoprotection #melanoma

15.01.2022 When used alongside sunscreens, these fabrics and clothes have been proven to reduce the risk of skin cancer significantly. Learn more: https://bit.ly/3cDTUCf #skincancer #skincancerawarness #worldcancerday #sunprotection #photoprotection

15.01.2022 A recent study, titled Demonstration of the dangerous nature of 'homemade' sunscreen recipes, sheds light on current consumer concerns within the sun protection industry. Read our most recent publication brief to find out more.CLINUVEL News: https://bit.ly/2KfL81d

15.01.2022 The diagnostic odyssey is just one part of the #RareDisease journey. Research by Naik et al has shown that one of the most pressing issues facing patients is a lack of information, even after diagnosis. As experts in the interaction of light and human biology, #CLINUVEL has developed tailored information for both patients and physicians available at www.EPP.Care. By #RaisingAwareness together we can help #SpotTheZebra #RareDiseaseDay

13.01.2022 CLINUVEL’s entrepreneurial approach has enabled the Company to continue growing. Read CLINUVEL chairman Willem Blijdorp’s most recent letter to shareholders to understand the next phase in CLINUVEL’s expansion: : https://bit.ly/3pATHnH

13.01.2022 #EPP is the most common form of porphyria in childhood. By the time patients are correctly diagnosed, the effects of a phototoxic reaction are ingrained. Over time, repeated EPP reactions cause many to develop fear and anxiety towards light exposure, leading to social isolation. #SpotTheZebra #RareDiseaseDay

09.01.2022 People with #rarediseases such as #EPP or #XP face an increased risk of additionally experiencing a mental health problem. With various restrictions in place to keep us safe during this global pandemic, life in isolation has become a familiarity to many of us. Understanding first-hand the strain it places on our health physically and mentally has allowed us to gain a glimpse of the limitations some patients are confronted with when leaving the house during daytime is a know...n risk factor in aggravating EPP and XP symptoms. Currently, more than 33% of countries allocate less than 1% of their total health budgets to mental health according to the WHO. Open discussions on mental health and further educating ourselves on less recognised diseases like EPP and XP can help combat discrimination against this major problem. To learn more visit: https://bit.ly/3iOPxUs

09.01.2022 There are various treatments available for ischaemic strokes, the majority of which intend to either remove or reduce the size of a blood clot or help the body prevent the reoccurrence of one. This particularly applies to patients who have experienced TIA or mini-strokes. Follow the link to learn more about ischaemic strokes: https://bit.ly/3lppo0C #AboutAIS

08.01.2022 CLINUVEL has released a strategic update on its business. The Update reveals CLINUVEL’s strategic intentions are described as dual: ongoing work to scientifically translate melanocortins as prescription medicines for further life-threatening disorders as well as making the technology available for healthcare solutions as non-prescription products. The focus of the latter product category is to provide DNA protection and repair of the skin in individuals at highest risk of sol...ar skin damage from UV exposure. Click the link to read the full update: https://bit.ly/37Q053V #ASX #Biotech #Australia #DNARepair #EPP

08.01.2022 Two cave explorers, Josie Laures and Antoine Senni, lived in two dark, desolate caves for months to test the effects of #isolation, #loneliness, and darkness. When Josie Laures came out of her cave on March 12, 1965, she thought it was February 25. A few days before Antoine Senni came out of his cave, on April 5 that same year, he thought it was February 4. Absent any cues from sunlight or even from clocks, Laures’s and Senni’s sleep schedules got wackysometimes without them realising it. #mentalhealthawarenessweek

08.01.2022 Who does vitiligo effect? The answer is anyone. Vitiligo doesn’t discriminate. Vitiligo affects both women and men equally, and there is no age limit for this condition, although most people usually spot the first signs of vitiligo before their 30s. Although depigmentation is more noticeable in those with a darker complexion, there’s limited evidence to suggest this disease is more prevalent in any one ethnicity. Find out more about #vitiligo here: https://bit.ly/3bRwUxB... #45millionvitiligovoices #vitiligoawareness

07.01.2022 Stroke is the second leading cause of death worldwide, accounting for 6.7 million deaths each year and taking a life every five seconds, according to the World Health Organization. Approximately 85% of all stroke cases are ischaemic strokes, caused by a blood clot in the brain which starves areas of the brain of oxygen. Around half of ischaemic strokes occur due to a blockage in the Middle Cerebral Artery (MCA), a territory unfortunately associated with poor recovery rates. ... CLINUVEL is evaluating whether afamelanotide can offer a treatment to patients ineligible for existing therapies. Head here for more: https://bit.ly/3kCdaBs #IschaemicStroke #stroketreatment #Stroke

06.01.2022 What does successful repigmentation mean in vitiligo? Read our latest brief to explore current views. | CLINUVELNews https://bit.ly/3m5Q1HT

04.01.2022 The trigger of #vitiligo is still unknown, but it causes our immune system to attack and destroy our melanin producing cells. Since melanin is the pigment that gives your skin, hair and eyes colour, white patches appear where this pigment is absent. Need to know more about vitiligo? Click here: https://bit.ly/3bRwUxB

04.01.2022 The results of our polls are in! Only 19% knew that sunscreen protects us from many of the harmful effects of the sun by either reflecting or absorbing UV rays. Misinformation has led 44% of you to believe unprotected sun exposure is required for our bodies to produce enough vitamin D. Some sunlight still penetrates your skin even through a high-SPF sunscreen, allowing vitamin D production. ... Learn fact from fiction about sun exposure here: https://bit.ly/39Q4Ta3 #skincancer #skincancerawarness #worldcancerday #sunprotection #photoprotection #sunscreen

03.01.2022 Research shows UV light exposure can be addictive, stimulating the production of chemicals that can leave habitual sun worshippers with withdrawal symptoms. Read more on the risks of tanning: https://bit.ly/3to6N9G #skincancer #skincancerawarness #worldcancerday #sunprotection #photoprotection #photoaging #addiction